Key result
Pediatric myocarditis and cardiomyopathies are heterogeneous disorders requiring a high index of suspicion, with treatment largely focused on supportive care and achieving hemodynamic stability.
This review highlights that pediatric myocarditis and cardiomyopathy have diverse etiologies and presentations, with management remaining largely supportive due to a lack of evidence for specific therapies.
Myocarditis represent an important condition encountered by general pediatricians & general practitioners. Its presentation is varied, and therefore a high index of suspicion must be maintained when the possibility of myocarditis is raised. A progression from viral myocarditis to dilated cardiomyopathy has long been hypothesized. Treatment is initially aimed at achieving hemodynamic stability and is largely supportive. There is currently little evidence to support the immunomodulatory or specific antiviral therapies. Pediatric cardiomyopathies are a heterogeneous group of disorders with diverse genetic, infectious, mitochodrial and metabolic etiologies. The timing and severity of presentation vary according to cardiomyopathy type as well as genetic and ethnic factors. The behavior of specific cardiomyopathies can be predicted by morphological and functional attributes, as well as underlying patient characteristics.
No takes yet. Share an insight, caveat, or question.
Hong Ryang Kil (2007) conducted a review in Myocarditis and cardiomyopathy in children. Pediatric myocarditis and cardiomyopathies are heterogeneous disorders requiring a high index of suspicion, with treatment largely focused on supportive care and achieving hemodynamic stability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: